New trial aims to stop pneumonia in ventilated kids with nebulized antibiotic
NCT ID NCT06488794
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests if giving a nebulized antibiotic (colistimethate sodium) can prevent pneumonia in children who are on breathing machines. About 400 children aged 1 month to 14 years will receive either the drug or a placebo twice daily for up to 7 days. The goal is to see if the treatment reduces the number of children who develop ventilator-associated pneumonia.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENTILATOR ASSOCIATED PNEUMONIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Speedier lab test could curb superbug threat in ICU pneumonia
- Human milk mouth care may shield preemies from lung infections
- Could a 'robotic cough' stop deadly pneumonia in ICU patients?
- Can a simple inhaled antibiotic stop deadly pneumonia in ventilator patients?
- AI reads chest X-Rays to spot deadly ICU lung infections
- Hospital study reveals key risk factors for superbug pneumonia